1Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90. 被引量：1
2Moses HL, Yang EY, Pietenpol JA. TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990; 63:245-7. 被引量：1
3Li MO, Wan YY, Sanjabi S, et al. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006; 24:99-146. 被引量：1
4Kriegel MA, Li MO, Sanjabi S, et al. Transforming growth factor-beta: recent advances on its role in immune tolerance. Curr Rheumatol Rep 2006; 8:138-44. 被引量：1
5Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359:693-9. 被引量：1
6Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342:1350-8. 被引量：1
7Gabrilovich 01, Chen HL, Girgis KR, et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 1996; 2:1096-103. 被引量：1
8Furlan 0, Sahnane N, Carnevali I, et al. Up-regulation of the hypoxia?inducible factor-l transcriptional pathway in colorectal carcinomas. Hum Pathol 2008; 39:1483-94. 被引量：1
9Huang CL, Liu 0, Ishikawa S, et al. Wntl overexpression promotes tumour progression in non-small cell lung cancer. Eur J Cancer 2008; 44: 2680-8. 被引量：1
10Oh SY, Kwon HC, Kim SH, et al. Clinicopathologic significance of HIF-lalpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer. BMC Cancer 2008; 8:123. 被引量：1
